Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,548,082
-
Share change
-
-326,130
-
Total reported value
-
$3,448,000
-
Price per share
-
$0.62
-
Number of holders
-
13
-
Value change
-
-$345,917
-
Number of buys
-
4
-
Number of sells
-
14
Institutional Holders of NOVUS THERAPEUTICS INC - COM (NVUS) as of Q3 2019
As of 30 Sep 2019,
NOVUS THERAPEUTICS INC - COM (NVUS) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,548,082 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, BVF INC/IL, 683 Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, BOXER CAPITAL, LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, BlackRock Inc., Virtu Financial LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.